Theoretical comparison between structural and dynamical features of dolastatins 11 and 12 antineoplastic depsipeptides

SAR and QSAR in Environmental Research

Volumn 14, Issue 5-6, 2003, Pages 475-484

  Alcaro, S ^a   Marino, T ^b   Ortuso, F ^a   Russo, N ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Dolastatins; F Actine; GRID; Molecular dynamics; Unusual aminoacids

Indexed keywords

BIOINFORMATICS; HYDROGEN BONDS; ISOMERS; MOLECULAR DYNAMICS;

ANTINEOPLASTIC; DEPSIPEPTIDES; DOLASTATIN; DYNAMICAL FEATURES; F-ACTINE; GRID; MOLECULAR MECHANICS CALCULATIONS; MOLECULAR-DYNAMICS CALCULATION; STRUCTURAL FEATURE; UNUSUAL AMINOACID;

PEPTIDES;

ANASPIDEA; AURICULARIA; DOLABELLA AURICULARIA; LEPUS;

EID: 0344121830     PISSN: 1062936X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10629360310001624042     Document Type: Conference Paper

References (30)

1. Blunden, G. (2001) "Biologically active compounds from marine organisms", Phytother. Res. 15, 89-94, and references therein.
2. Baker, J.T. (1984) "Modern drug research: the potential and the problems of marine natural products", In: Krogsgaard-Larsen, P.K., Brogger Christensen, S. and Kofod, H., eds, Natural Products and Drug Development (Munksgaard, Copenhagen), pp 145-163.
3. Cheng, C.C. (1988) "Structural aspects of antineoplastic agents - a new approach", In: Ellis, G.P. and West, G.B., eds, Progress in Medicinal Chemistry (Elsevier Science Publishers, B.V., Amsterdam) 25, pp 35-83.
4. Spector, I., Braet, F., Shochet, N.R. and Bubb, M.R. (1999) "New anti-actin drugs in the study of the organization and function of the actin cytoskeleton", Microsc. Res. Tech. 47, 18-37.
5. Bai, R., Bates, R.B., Hamel, E., Moore, R.E., Nakkiew, P., Pettit, G.R. and Sufi, B.A. (2002) "Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadening", J. Nat. Prod. 65, 1824-1829.
6. Pettit, G.R., Kamano, Y., Herald, C.L., Fujii, Y., Kizu, H., Boyd, M.R., Boettner, F.E., Doubek, D.L., Schmidt, J.M. and Chapuis, J.-C. (1993) "Isolation of dolastatins 10-15 from the marine mollusc Dolabella Auricularia", Tetrahedron 41, 9151, Refs. quoted herein.
7. Pettit, G.R., Kamano, Y., Kizu, H., Dufresne, C., Herald, C.L., Bontems, R.J., Schmidt, J.M., Boettner, F.E. and Nieman, R.A. (1989) "Isolation and structure of the cell growth inhibitory depsipeptides dolastatins 11 and 12", Heterocycles 28, 553-558.
8. Pettit, G.R. (1997) "The dolastatins", Prog. Chem. Org. Nat. Prod. 70, 1-79.
9. Jacobsen, S.E.W., Ruscetti, F.W., Longo, D.L. and Keller, J.R. (1991) "Antineoplastic dolastatins: potent inhibitors of hematopoietic progenitor cells", J. Natl. Cancer Inst. 83, 1672.
10. Harrigan, G.G., Yoshida, W.Y., Moore, R.E., Nagle, D.G., Park, P.U., Biggs, J., Paul, V.J., Mooberry, S.L., Corbett, T.H. and Valeriote, F.A. (1998) "Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages", J. Nat. Prod. 61, 1221-1225.
11. Bai, R., Pettit, G.R. and Hamel, E. (1990) "Dolastatin 10, a powerful cytostatic peptide derived from a marine animal", Biochem. Pharmacol. 39, 1941.
12. Bubb, M.R., Senderowicz, A.M.J., Sausville, E.A., Duncan, K.L.K. and Korn, E.D. (1994) "Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin", J. Biol. Chem. 269, 14869-14871.
13. Bai, R., Schwartz, R.E., Kepler, J.A., Pettit, G.R. and Hamel, E. (1996) "Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction", Cancer Res. 56, 4398-4406.
14. Bai, R., Friedman, S.J., Pettit, G.R. and Hamel, E. (1992) "Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia", Biochem. Pharmacol. 43, 2637.
15. Beckwith, M., Urba, W.J. and Longo, D.L. (1993) "Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15", J. Natl. Cancer Inst. 85, 483.
16. Hu, Z., Gignac, S.M., Quentmeier, H., Pettit, G.R. and Drexler, H.G. (1993) "Effects of dolastatins on human B-lymphocytic leukemia cell lines", Leukemia Res. 17, 333.
17. Bai, R., Pettit, G.R. and Hamel, E. (1990) "Structure-activity studies with chiral isomers and with segments of the antimitotic marine peptide dolastatin 10", Biochem. Pharmacol. 40, 1859.
18. Bai, R., Pettit, G.R. and Hamel, E. (1990) "Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and Vinca alkaloid sites", J. Biol. Chem. 28, 17141.
19. Bai, R., Roach, M.C., Jayaram, S.K., Barkoczy, J., Pettit, G.R., Ludueña, R.F. and Hamel, E. (1993) "Differential effects of active isomers, segments, and analogues of dolastatin 10 on ligand interactions with tubulin", Biochem. Pharmacol. 45, 1503.
20. Pettit, G.R., Singh, S.B., Hogan, F., Lloyd-Williams, P., Herald, D.L., Burkett, D.D. and Clelow, P.J. (1989) "The absolute configuration and synthesis of natural (-)-dolastatin 10", J. Am. Chem. Soc. 111, 5463.
21. Bates, R.B., Brusoe, K.G., Burns, J.J., Caldera, S., Cui, W., Gangwar, S., Gramme, M.R., McClure, K.J., Rouen, G.P., Schadow, H., et al (1997) "Synthesis and stereochemistry of dolastatin 11", J. Am. Chem. Soc. 119, 2111-2113.
22. Bates, R.B. and Gangwar, S. (1993) "Asymmetric syntheses of 3-amino-2-methylpentanoic acids. Configurations of the beta-amino acid in majusculamide C, 57-normajusculamide C and dolastatins 11 and 12", Tetrahedron: Asymm. 4, 69-72.
23. Bai, R., Verdier-Pinard, P., Gangwar, S., Stessman, C.C., McClure, K.J., Sausville, E.A., Pettit, G.R., Bates, R.B. and Hamel, E. (2001) "Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin", Mol. Pharmacol. 59, 462-469.
24. Oda, T., Crane, Z.D., Dicus, C.W., Sufi, B.A. and Bates, R.B. (2003) "Dolastatin 11 connects two long-pitch strands in F-actin to stabilize microfilaments", J. Mol. Biol. 328, 319-324.
25. Galéotti, N., Poncet, J. and Jouin, P. (2002) "Post-source decay analysis of dolastatin 10 and dolastatin 15 by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry", Eur. J. Mass Spectrom. 8, 311-321.
26. Biosym Technologies Inc. Insight/Discover codes. Biosym Technologies Inc., San Diego, Calif, USA.
27. Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, J., Genest, M. and Hagler, A.T. (1988) "Structure and energetics of ligand-binding to proteins: Escherichia coli dihydrofolate reductase/ trimethoprim, a drug-receptor system", Protein: Struct. Funct. Gene. 4, 31.
28. Fantucci, P., Marino, T., Russo, N. and Villa, A.M. (1995) "Conformational behaviour of the antineoplastic peptide dolastatin-10 and of two mutated derivatives", J. Comp-Aided Mol. Des. 9, 425-438.
29. Goodford, P.J. (1985) "A Computational procedure for determining energetically favorable binding sites on biologically important macromolecules", J. Med. Chem. 28, 849.
30. The standard parameters for each probe are those reported in the database file grub.dat as included in the version 17 of the program GRID (Molecular Discovery Ltd, West Way House, Elms Parade, Oxford, England).